UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$34,126,640
-$15,242,078 QoQ
Shares Held
528,031
-28.0% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58.47895294026297.ToString("F0")%
Shared 0.ToString("F0")%
None 41.52104705973702.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. HALO ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,126,640 | 528,031 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $49,368,718 | 733,562 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $23,979,754 | 326,967 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,819,809 | 496,344 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,561,674 | 416,262 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $18,639,919 | 389,875 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,771,957 | 397,833 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,620,770 | 432,024 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $6,547,607 | 160,954 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,957,210 | 161,180 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,017,911 | 157,537 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,069,307 | 334,608 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,778,677 | 334,608 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,501,453 | 518,479 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,558,860 | 519,951 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,782,016 | 176,864 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,678,501 | 167,465 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,066,399 | 150,868 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,009,980 | 147,738 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,051,943 | 155,295 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,299,441 | 151,102 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,584,897 | 154,177 | Shares | Sole | 2021-03-01 | |
| 2020-09-30 | $3,710,733 | 141,200 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,897,957 | 145,392 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,708,722 | 873,192 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||